The interesting thing about a $32 billion insurance deal is how little the customer may see. In July 2025, Reinsurance Group of America, Incorporated closed a transaction covering a large slice of Equitable’s existing life insurance business. Equitable would still administer the policies and support policyholders. Behind that familiar relationship, a substantial share of the financial risk had moved.
- RGA shares life and health insurers’ risks in exchange for premiums.
- It also supplies capital solutions, underwriting tools, and product expertise.
- The Equitable deal separates three things often confused: the policy, the customer relationship, and the risk.
This is the peculiar business of reinsurance. The company whose name appears on the policy can remain the customer’s point of contact while another company carries an agreed portion of the exposure. RGA works in that second layer, where an insurer’s promises meet the arithmetic required to keep them.
01 A very large number, carefully unpacked
Start with the number on the announcement. The $32 billion block comprised roughly $18 billion of general account reserves and $14 billion of separate account reserves. RGA agreed to reinsure 75% of the specified in-force life insurance liabilities. Those figures describe the business involved; they do not describe a $32 billion cheque.
RGA expected to deploy $1.5 billion of capital at closing. Equitable, meanwhile, said the transaction would generate more than $2 billion of value through a positive ceding commission and released capital. These are different measures belonging to different sides of the agreement. Put them in one bucket and the economics become nonsense.
The attraction for Equitable was explicit: less exposure to future mortality volatility and more focus on retirement, asset management, and wealth management. For RGA, the arrangement expanded a relationship spanning underwriting, product development, distribution, and investments. Moving an existing book could also open the door to building future business together.
02 The factory behind the policy
RGA began as a reinsurance division within General American Life in 1973. Its specialism remains life and health: mortality, illness, disability, and longevity. It occupies the wholesale layer of insurance, alongside alternatives such as Munich Re, Swiss Re, Hannover Re, SCOR, and Gen Re. A family shopping for cover is generally shopping elsewhere.
An insurer has several reasons to call. It may need to share claims exposure, free capital for growth, price a difficult medical case, or design a new product. RGA’s offering stretches from individual case assessment, called facultative underwriting, to financial solutions involving assets, pensions, and longevity. Its expertise combines medical interpretation, actuarial modelling, investment management, and local insurance practice.
Consider longevity. A life insurer worries about paying death claims sooner than expected; a pension arrangement can face the opposite problem, paying benefits for longer than expected. Both require assumptions about human survival. RGA works on these different exposures through distinct contracts. The customer’s problem determines the structure. A useful reinsurer needs to understand what a client is trying to protect before deciding which risk it can take.
The distinction is useful. A software supplier can help an insurer make decisions. A reinsurer can help make those decisions and accept a contractual share of their consequences. That combination links advice to exposure. RGA’s stated purpose, “To make financial protection accessible to all,” depends on making more risks insurable at a price the parties can sustain.
03 The missing machinery
A published RGA case study supplies a smaller, revealing example. A property and casualty insurer wanted to expand into life insurance. It already had customers and distribution. Those customers were going elsewhere for life cover. What the carrier lacked was the infrastructure to develop and implement the product.
RGA helped design, price, and file a term life offering sold through the carrier’s website. Its specialists built underwriting and claims processes, with automation supplied by Aura Next. After implementation, the teams continued reviewing the rules to improve the proportion of applications moving through the system. Launch was one stage in the work.
- DesignProduct + price
- DecideUnderwriting + evidence
- RevisitMonitor + adjust
Aura Next is offered as software as a service, with annually renewable subscriptions and no upfront licence fee. It supports adaptive interviews, underwriting rules, and outside evidence. In its April 2025 case study, RGA reported more than 50 clients in 18 countries using the technology to process over five million applications annually. That is platform usage, rather than a count of RGA’s entire customer base.
The lesson a product team can borrow is specific: put pricing, decision rules, and operating processes in the same conversation, then watch what happens after release. Automating a poorly chosen rule simply applies the mistake more consistently. Speed needs a feedback loop.
04 The year the assumptions got expensive
There is a limit to the comfort of a mortality model. In 2021, RGA reported approximately $1.4 billion of global estimated pre-tax COVID-19 impacts. Full-year adjusted operating earnings fell to $1.13 per diluted share from $7.54 in 2020. The business built to absorb mortality risk had absorbed a costly dose of it.
Capital provides another part of the explanation. In June 2020, RGA raised $500 million through a public stock offering to add a buffer amid pandemic uncertainty. Its annual report described the money as supporting flexibility and stability. That is a tangible cost of maintaining the capacity to absorb shocks: more funding must be available when the range of possible outcomes widens. A mortality database cannot substitute for the balance sheet standing behind it.
The pressure showed up in claims and earnings. Geographic reach could not prevent a pandemic from affecting several populations at once. For readers studying the model, this is the boundary condition: sharing a risk does not make the underlying event disappear. Pricing, reserves, investment performance, and capital still have to withstand what actually happens.
Sharing a risk does not make the underlying event disappear.The economic catch
05 Global data, local questions
RGA’s Korean operation illustrates why scale alone is insufficient. It opened a Seoul representative office in 2002 and helped develop and price Korea’s first contemporary critical illness product. Today its Korean offering includes research, product development, underwriting, actuarial work, and data analysis. Local product needs still shape the use of global expertise.
The pattern continued in March 2026, when RGA announced a partnership with Vietnam’s Techcom Life covering product innovation, technical support, and execution. By August, RGA had reported second-quarter shareholder net income of $462 million. Growth brings more promises onto the system. The enduring question is whether the people pricing those promises understand both the statistics and the lives behind them.